Literature DB >> 32976956

Immobilization of vaginal Lactobacillus in polymeric nanofibers for its incorporation in vaginal probiotic products.

Jessica Alejandra Silva1, Priscilla Romina De Gregorio2, Guadalupe Rivero3, Gustavo A Abraham3, María Elena Fátima Nader-Macías4.   

Abstract

Probiotic products require high number of viable and active microorganisms during storage. In this work, the survival of human vaginal Lactobacillus gasseri CRL1320 and Lactobacillus rhamnosus CRL1332 after nanofiber-immobilization by electrospinning with polyvinyl-alcohol, and during storage was evaluated. The optimization of bacterial immobilization and storage conditions using bioprotectors (skim milk-lactose and glycerol) and oxygen-excluding packaging was carried out, compared with lyophilization. After electrospinning, a higher survival rate of L. rhamnosus (93%) compared to L. gasseri (84%) was obtained in nanofibers, with high viable cells (>107 colony-forming unit/g) of the two probiotics in nanofibers stored at -20°C up to 14 days. The storage in oxygen-excluding packaging was an excellent strategy to extend the shelf-life of L. rhamnosus (up to 1.7 × 108 CFU/g) in nanofibers stored at 4°C during 360 days, with no addition of bioprotectives, resulting similar to freeze-dried-cells. L. rhamnosus was successfully incorporated into polymeric hydrophilic nanofibers with a mean diameter of 95 nm. The composite materials were characterized in terms of morphology, and their physicochemical and thermal properties assessed. Nanofiber-immobilized L. rhamnosus cells maintained the inhibition to urogenital pathogens. Thus, polymeric nanofiber-immobilized L. rhamnosus CRL1332 can be included in vaginal probiotic products to prevent or treat urogenital infections.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial immobilization; Electrospinning; Freeze-dried; Lactobacillus; Nanofibers; Vaginal probiotic

Mesh:

Year:  2020        PMID: 32976956     DOI: 10.1016/j.ejps.2020.105563

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

Review 1.  Insights on the Critical Parameters Affecting the Probiotic Viability During Stabilization Process and Formulation Development.

Authors:  Sharda Gurram; Durgesh K Jha; Devanshi S Shah; Madhuri M Kshirsagar; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2021-05-18       Impact factor: 3.246

2.  Evaluation of the anticandidal activity of clotrimazole using Lactobacillus caseie ghosts as biological drug carrier.

Authors:  Touba Eslaminejad; Mohammad Hassan Moshafi; Matineh Hasanpore; Seyed Amin Ayatollahi; Mehdi Ansari
Journal:  Daru       Date:  2022-03-15       Impact factor: 4.088

Review 3.  Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection.

Authors:  Priyadarshini Chandrashekhar; Farnaz Minooei; Wenndy Arreguin; Mohammadali Masigol; Jill M Steinbach-Rankins
Journal:  AAPS J       Date:  2021-05-10       Impact factor: 4.009

4.  Influence of Excipient Composition on Survival of Vaginal Lactobacilli in Electrospun Nanofibers.

Authors:  Spase Stojanov; Julijana Kristl; Špela Zupančič; Aleš Berlec
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

Review 5.  Nanomaterial-based encapsulation for controlled gastrointestinal delivery of viable probiotic bacteria.

Authors:  Seyedehhamideh Razavi; Sajjad Janfaza; Nishat Tasnim; Deanna L Gibson; Mina Hoorfar
Journal:  Nanoscale Adv       Date:  2021-03-30

6.  Engineering of Vaginal Lactobacilli to Express Fluorescent Proteins Enables the Analysis of Their Mixture in Nanofibers.

Authors:  Spase Stojanov; Tina Vida Plavec; Julijana Kristl; Špela Zupančič; Aleš Berlec
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

Review 7.  Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract.

Authors:  María Elena Fátima Nader-Macías; Priscilla Romina De Gregorio; Jessica Alejandra Silva
Journal:  Pharmacol Res Perspect       Date:  2021-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.